Ischemic preconditioning (IPC) is a phenomenon in which a short-term sublethal ischemic exposure induces tolerance to a subsequent lethal ischemic insult; however, the detailed mechanism underlying IPC-induced neuroprotection remains obscure.
Introduction
The non-idiopathic stroke is characterized by temporary or permanent neuronal impairment caused by acute dysfunction of cerebral blood circulation to central lobes or hemorrhage-induced intracerebral bleeding (Huang and McNamara, 2004) . During an ischemic stroke, a local shortage of blood supply to the brain leads to a dramatic decrease of oxygen and glucose, a breakdown of ATP production, and ultimately dysfunction of brain energy metabolism (Sims and Muyderman, 2010) . Recent epidemiological reviews of stroke incidence in China illustrate that both morbidity (5.54 to 8.34 per 1000) (Wu et al., 2013) and mortality (109.13 to 121.57 per 100,000) (Sun et al., 2013) increase within two decades, presenting a lethal public health challenge. Presently, effective treatment or drug options are lacking in clinical practice. Limited knowledge of the molecular mechanisms underlying the pathological process of ischemia-reperfusion injury (IRI) is a major challenge restricting the development of treatments and drugs. Among several models that are widely used to explore the mechanisms and treatments of stroke, cerebral ischemic preconditioning (IPC) is counterintuitive but intriguing and promising. Cerebral IPC can be defined as a phenomenon in which both a short-term and non-lethal ischemic episodes increase the preventative tolerance of neurons in response to subsequent long-term and lethal ischemic damage, thus acting as a neuroprotective shielding to brain cellular stress (Yang et al., 2017) . Kitagawa and colleagues first reported that two minutes of cerebral ischemia in advance ameliorated the neuronal death caused by a subsequent 5 min treatment (Kitagawa et al., 1990 ).
The concept of cerebral IPC has been applied in both clinical trials and animal models. For example, a randomized pilot study during a phase II trial of patients with acute ischemic stroke symptoms showed improved neurological outcomes when treated with Remote Ischemic Conditioning After Stroke Trial (RECAST). This clinical trial showed that Remote Ischemic Conditioning (RIC) induced neuroprotection to mitigate symptoms such as intermittent limb ischemia in stroke patients (England et al., 2017) . Besides, various mouse models have allowed for a controlled and standardized reproduction of cerebral ischemia; these advances have led to the application of various mouse systems to simulate IPC, such as remote limb ischemic preconditioning models, global ischemia models, and focal ischemia models
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4 (Schaller and Graf, 2002) . Here, we will explore the mechanisms that underlie middle cerebral artery occlusion (MCAO), a focal ischemia model that is implemented in this study. In this model system, a surgical filament is used to obstruct the middle cerebral artery, which leads to the blockage of blood, and thus infraction of cerebrum (Chiang et al., 2011) . If the occlusion is removed during a transit interval (such as 15 min, 30 min or 1h) and blood flow is allowed to return the cerebrum, then this procedure can be viewed as comparable to an IPC treatment (Stenzel-Poore et al., 2003) .
As a phenomenon showing potential clinical importance, cerebral IPC attracts intensive research programs with identification of several novel genes of interest and their function in both pathophysiology and neuroprotection. Previous clinical trial suggested that Heat Shock Protein 27 (HSP27) mediated neuroprotective effects (England et al., 2017) . In mouse models, RIC induced neuroprotection was promoted through the adenosine monophosphate-activated protein kinase (AMPK) mediated immune regulation and autophagy (Guo et al., 2018; Vaibhav et al., 2018) .
Additionally, cerebral IPC also induces the upregulation of Notch1, which suggests the activation of related Notch signaling pathways during neuroprotection (Chen et al., 2018) . Specifically, it was further described that nitric oxidation-induced activation of the Ras/extracellular regulated kinase cascade played an important role in IPC (Gonzalez-Zulueta et al., 2000) . Besides, IPC induced neuroprotection can be abolished by protein synthesis inhibitors, suggesting that new protein synthesis is required for protection (Zhang et al., 2009 ).
Epigenetic mechanisms are also involved in IPC, such as DNA methylation, histone modification, non-coding RNA, and micro-RNA; the role of DNA methylation as an independent factor in IPC is still controversial (Thompson et al., 2013; Lopez et al., 2016) . Regardless, it has been observed in stroke patients, RIC was able to modify expression patterns of several genes through regional DNA methylation, such as CEACAM8 and CRISP3 (Elina Nikkola 2018). In terms of mouse models, the 30 min MCAO was shown to reduce DNA methylation, and the scopes of infarcts induced by MCAO treatment were smaller in DNA methyltransferase knockout mice than in control mice (Endres et al., 2000) . These results suggest a significant linkage does exist between neuroprotection and DNA hypo-methylation.
However, it was uniquely noted that decreased levels of DNA methyltransferase 1
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A C C E P T E D M A N U S C R I P T 5 (Dnmt1), rather than the absence of Dnmt1, showed neuroprotective effects (Endres et al., 2001) . Generally, various ischemic conditions have been shown to produce diverse and dynamic DNA methylation profiles (Meller et al., 2015) . Overall, the relation between DNA methylation and cerebral IPC needs further exploration to uncover and translate the molecular mechanisms underlining such an association.
In this study, we used an ischemic preconditioning mouse model through MCAO and performed RNA-seq and whole-genome bisulfite sequencing to characterize the gene expression profile and changes in whole-genome methylation after cerebral IPC treatment. Arid5a, Stc2, and Nptx2 were identified as IPC-inducible genes and provided neuroprotective functions during ischemic injury.
Experimental procedures
Transient Focal Ischemia
Cerebral focal ischemia was induced by occlusion of the middle cerebral artery.
To avoid possible sex-specific sensitivity to ischemic tolerance, only C57 male mice which were purchased from the Laboratory Animal Center of the Military Medical Sciences Academy were subjected to MCAO as described previously (Andrabi et al., 2011; Zhang et al., 2016; Zhang et al., 2018) . In brief, mice were anesthetized with 1.5-2% isoflurane and maintained at 37°C throughout the surgical procedure using a heating pad and rectal probe (Harvard Apparatus, USA). A monofilament coated with silicone was inserted via a small nick in the right external carotid artery and slowly pushed through the right internal carotid artery until it reached the base of the middle cerebral artery to block the blood flow into the middle cerebral artery brain territory.
For MCAO ischemic precondition, 15 min of occlusion was performed in the mice as described previously (Stenzel-Poore et al., 2003) . Blood flow to the brain during the entire occlusion phase and reperfusion was monitored by Laser Doppler flowmetry with a probe placed directly on the exposed skull over the lateral parietal cortex. After 15 min of occlusion, the filament was removed, and reperfusion was verified. Mice with average blood flow records that dropped below 80% of the baseline value were included in the experiments. Besides, any mice died during the surgery were excluded for analysis. Based on our previous studies (Zhang et al., 2016; Zhang et al., 2018) and other researchers' findings (Andrabi et al., 2011) to characterize the early changes
in the DNA methylation and RNA transcription, animal brains were removed at 6 hours after IPC, and the ipsilateral cortex which was subject to IPC treatment and the corresponding contralateral undamaged cortex which served as the control of the same brain were collected and frozen at -80°C for the following experiments. All animal experiments were conducted with the approval of the Institutional Animal
Care and Use Committees at the Peking Union Medical College.
Whole Transcriptome Library Preparation and RNA-sequencing Analysis
Total RNA was isolated from ipsilateral and contralateral cortices from three mouse brains and subjected to quality control according to the manufacturer's instructions. 
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A C C E P T E D M A N U S C R I P T 7 2010), in which gene length bias was corrected, and a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed using KOBAS software (Mao et al., 2005) .
WGBS Library Preparation, Sequencing and Analysis
Genomic DNA samples were isolated from ipsilateral and contralateral cortices of mouse brains using a DNeasy Blood & Tissue Kit according to the manufacturer's instructions. A total of 500 ng of DNA spiked with 5 ng of lambda DNA (Promega, Madison, WI) per sample was fragmented to 250-350 bp by sonication with a Covaris M220, followed by end repair and methylated adaptor ligation. These DNA fragments were treated with bisulfite using an EZ DNA Methylation-Gold TM Kit. The obtained single-strand DNA fragments were amplified by PCR using KAPA HiFi HotStart Uracil + ReadyMix (2x) followed by purification by AMPure XP magnetic beads.
The library concentration was quantified by a Qubit 2.0 Fluorometer, and the insert size was assessed on an Agilent Bioanalyzer 2100 system. After clustering the indexcoded samples, which was performed on a cBot Cluster Generation System using a
TruSeq PE Cluster Kit v3-cBot-HS, the library was sequenced on an Illumina HiSeq 2500 platform, and 150 bp paired-end reads were generated according to Illumina's protocol. Prior to data analysis, adapter oligonucleotide sequences were removed from the raw sequencing data, and the individual libraries were converted to the FASTQ format. Additionally, reads with a percentage of Ns (unknown bases) that was larger than 10% and low quality (PHRED score ≤ 5, percentage of low-quality bases ≥ 50%)
were also filtered out. Sequencing reads were analyzed using the BSmooth software package (Hansen et al., 2012) . The sodium bisulfite non-conversion rate was calculated as the percentage of cytosines sequenced at cytosine reference positions in the lambda genome. To identify differentially methylated regions (DMRs), the BSseq package in BSmooth was employed. Only CpGs appearing at least twice in at least two samples per group were included in the analysis. DMRs were identified using a smooth window containing either 70 CpGs or a width of 1 kb, whichever was larger.
Next, regions satisfying the following criteria were deemed putative DMRs: 1) a tstatistic cut-off of (-2.5, 2.5); 2) must contain at least 3 CpG sites; and 3) must have a methylation difference of at least 10%. All data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO ACCEPTED MANUSCRIPT
Series accession number GSE122107.
Bisulfite Sequencing
Bisulfite conversion of genomic DNA was performed according to the instructions of EZ DNA Methylation-Direct TM Kit (Zymo Research, USA) followed by nested PCR for the amplification of the DMRs (Bakulski KM et al., 2015) . The primer sequences were listed in Table 3 . The PCR products were detected on 2%
agarose gel and then sequenced on the PyroMark Q24 platform.
Gene Expression Validation by Western Blotting
Total protein extracts were prepared from the ipsilateral and contralateral cortices of eight mice and size-separated through SDS/PAGE as described previously (Zhang et al., 2011a) . After electrophoresis, the separated proteins were transferred onto a nitrocellulose membrane. Membranes were blocked in TBST buffer (20 mM
Tris base, 150 mM NaCl, 0.05% Tween 20, pH 7.4) containing 5% nonfat milk at room temperature for 2 h prior to incubation with primary antibody at 4°C overnight.
TBST-washed membranes were incubated with goat anti-rabbit (Santa Cruz, sc-2004, Lot # A1416) or goat anti-mouse (Santa Cruz, sc-2005, Lot #J2215) secondary antibodies in TBST with 5% nonfat milk and then washed with TBST, and membrane-bound antibody was visualized in a chemiluminescence assay. Betatubulin was used for normalization. Anti-Arid5a polyclonal antibody (Lot #ab81207) was purchased from Abcam, anti-Nptx2 polyclonal antibody (Lot #10889-1-AP) and anti-Stc2 monoclonal antibody (Lot #60063-1-Ig) were purchased from Proteintech, and anti-beta-tubulin antibody (Lot # 030M4788) was purchased from Sigma Applied Science.
Construction of the Overexpression Vectors and Lentivirus Generation
Arid5a, Nptx2 and Stc2 open reading frames (ORF) were purchased from OriGene and subsequently cloned into a cFUGW-GFP lentiviral vector using the multiple clone sites. Lentiviral constructs were generated by transient transfection of 293T cells by using the FuGENE HD Transfection Reagent by Roche Applied Science as described previously (Zhang et al., 2011a) . In brief, cells were cotransfected with the vector plasmid (cFUGW-GFP, cFUGW-Arid5a, cFUGW-Nptx2
and cFUGW-Stc2), the trans-complementation plasmids (pLP1 and pLP2), and the plasmid encoding the vesicular stomatitis virus envelope glycoprotein (VSVG).
Sodium butyrate was added to the media 4-6 h after transfection. The medium was replaced 12 h after transfection and collected at 36 h and 60 h later. Supernatants were centrifuged at 800 × g for 10 min, treated with DNase and passed through a filter with 0.45-mm pores. Viral particles were then concentrated by ultracentrifugation (90 min, 25,000 r/min, rotor SW28) and resuspended in 0.1 M PBS.
Neuronal Cultures and Ischemic Modeling
Primary cortical neuron cultures were prepared from gestational day 14.5 fetal mice as previously described (Dai et al., 2010) . In mature cultures, neurons represent approximately 80% of the total number of cells. Neurons were transduced with the overexpressing lentiviral constructs at 7 days in vitro (DIV). Three days later, an in vitro equivalent of ischemic modeling was used, whereby the neurons were subjected to oxygen-glucose deprivation (OGD) as previously described (Dai et al., 2010; Zhang et al., 2018 
Results
Transcriptome Profile of IPC-treated Cerebral Cortexes
To investigate the mechanisms underlying the neuroprotective function of ischemic preconditioning, mice weighing 20-23 g were subject to 15 min MCAO
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T 10 ( Figure 1A ). Laser Doppler ultrasonography and perfusion imagery were applied to monitor brain blood flow. The baseline blood flow was considered to be 100% for all mice; any mice with average blood flow records that dropped below 80% value were included in the further molecular analysis experiments ( Figure 1B ). After common carotid artery occlusion (CCAO), the first blood flow decline was noted and occlusion of the middle cerebral artery led to the second reduction in blood flow ( Figure 1B ).
Over the 15 min period of occlusion, cortical perfusion monitored by Laser Doppler ultrasonography was reduced 84.12±0.32% of baseline. The reduction was stable throughout the occlusion period and recovered to pre-ischemic levels upon removal of the filament ( Figure 1B ). Mice were divided into three groups: for RNA-seq, for proteins examination, and for the DNA methylation analysis ( Figure 1A ).
To explore the transcriptional profile of IPC-treated cerebral cortexes, total RNA was extracted from the ipsilateral and contralateral cerebral cortexes from the same mouse brain. The contralateral undamaged cerebral cortexes were used as controls.
RNA-sequencing results demonstrated a significant difference between the two groups ( Figure 1C ). With the standard of fold change < 0.5 or > 2 and FDR < 0.05, we identified 594 upregulated and 42 downregulated genes as shown in the volcano plot ( Figure 1D ).
Bioinformatic Analysis of DEGs in IPC-treated Cerebral Cortexes
Next, we performed a cluster analysis of the DEGs between the IPC-treated and contralateral cerebral cortexes. As shown in Figure 2A , the contrasting treatment and control groups showed significantly different gene expression patterns, but in the same group, all samples showed similar gene expression patterns.
To ascertain the functions of the DEGs (594 upregulated and 42 downregulated genes), we first performed GO term enrichment analyses using GO-seq. Significantly overrepresented terms of the DEGs are shown in Figure 2B We also performed a KEGG pathway analysis of the DEGs between the IPCtreated and control groups. The results showed that these DEGs were connected to several partially overlapping and interconnected pathways, including the PI3K-Akt signaling pathway, the MAPK signaling pathway, human papillomavirus infection, HTLV-1 infection, transcriptional mis-regulation in cancer, osteoclast differentiation, the TNF signaling pathway and the ECM-receptor interaction pathway ( Figure 2C ).
The top 30 upregulated genes are listed in Table 1 . Indeed, many of the genes identified in this screening have not been previously linked to IPC signaling pathways. Thus, these results provide novel insights into IPC signaling pathways.
IPC-induced Global DNA Methylation Profile and DMRs
To further explore how the DEGs were regulated during IPC, we also performed WGBS to characterize the profile of whole-genome DNA methylation after IPC treatment. A total of 1 668 004 204 clean reads were obtained. The mapping rates were 95.06% and 95.82% in the IPC-treated and contralateral cerebral cortexes, respectively, and the bisulfite conversion rates were over 99.5% in both groups. We also calculated the methylation level of each cytosine. A total of 43 735 674 CpG sites were mapped, and the coverage rates were 81.89% and 80.79% in the IPC-treated and control cortexes, respectively. The percentages of methylated cytosines (mCs) in the IPC-treated and control cortexes were 72.96% and 72.90%, respectively. All of these results suggest that the WGBS libraries were well prepared and sequenced in both groups.
Next, we performed the DMR analysis and identified 10799 DMRs and 6865 DMRrelated genes in the genomic regions (including the 5′UTR region, 3′UTR region, promoter, upstream, downstream, intron and exon) in the IPC-treated samples compared to those in the controls ( Figure 3A) . We found that more DMRs were distributed in the intronic regions, although the promoter regions were also noted to ACCEPTED MANUSCRIPT
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The Link Between DNA Methylation and Gene Expression
To ascertain the potential relationship exists between DNA methylation and individual gene expression induced by IPC, we linked and cross-analyzed the gene list from WGBS and actively compared this data to identified DEGs obtained using RNAseq. The results showed that the RNA expression levels of 355 genes were significantly linked to the DNA methylation changes in 531 DMRs ( Figure 4A ). We then classified DMRs into four groups according to the hypo-or hypermethylation and down-or upregulation of RNA expression ( Figure 4B ). We found that 151 upregulated genes showed hypomethylation in their DMRs and that only 15 downregulated genes displayed hypermethylation in their DMRs. We also found negative correlations between RNA expression and DMRs located in exons, in introns, overlapping the 3'UTR, overlapping the 5'UTR, overlapping an exon downstream, and overlapping an exon upstream ( Figure 4C ). These results suggest extensive demethylation in the regulatory regions of many neuroprotective genes, initiating gene expression and protein synthesis after IPC treatment.
Overexpression of IPC-induced Genes Elicits Neuroprotection
In consideration of the results from both RNA-seq and DNA methylation, we selected 3 unique mRNA genes that were upregulated, namely Arid5a, Nptx2 and Stc2, and two of which were shown to be hypo-methylated in their DMRs. The overall mean methylation level at the Arid5a DMR was significantly reduced 15.08% in IPCtreatment. For the Nptx2 DMR, the mean methylation level was reduced 13.31% except for the DMR in inside exon (Table 2 ). Individual CpG analysis was determined by bisulfite pyro-sequence indicating that IPC induced hypo-methylation of Arid5a DMR and Nptx2 DMR at several sites ( Figure 5A and 5B). Western blots verified that the expression levels of Arid5a, Nptx2 and Stc2 were significantly increased after IPC in the mouse MCAO model ( Figure 5C and 5D).
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To ascertain whether these upregulated genes have potential neuroprotective actions, we prepared lentiviruses expressing Arid5a, Nptx2 and Stc2 individually and used the vectors to transduce primary cortical neurons followed by exposure to OGD.
Western blots showed that lentiviral transduction led to significant overexpression of Arid5a, Nptx2 and Stc2 proteins in HEK293T cells ( Figure 5E ). For the primary neuronal cultures, we found that overexpression of Arid5a provided approximately 60% protection against OGD-induced cell death, whereas overexpression of Nptx2
and Stc2 showed approximately 50% and 35% protection, respectively ( Figure 5F and 5G). Taken together, these results indicate that IPC-induced gene upregulation provides neuroprotection against subsequent lethal ischemic injury.
Discussion
IPC is a powerful endogenous phenomenon in which a brief sublethal ischemic insult induces robust protection against subsequent lethal ischemia (Yang et al., 2017) . Although the exact mechanisms of IPC-induced neuroprotection remain unclear, this powerful mechanism holds substantial promise to identify novel neuroprotective agents that could be used to treat various neurological disorders including stroke. In this study, we characterized the profiles of gene expression and whole-genome methylation by RNA-seq and WGBS in an IPC-treated mouse model of MCAO and identified several novel genes related to cerebral IPC. Therefore, our findings provide novel insights for the investigating IPC signaling pathways and the mechanisms of ischemia-induced neuronal cell death and survival. We also identified Arid5a, Stc2, and Nptx2 as IPC-inducible genes that were upregulated and demonstrated neuroprotective functions during ischemic injury.
It is believed that new protein synthesis is required for IPC-induced protection (Barone et al., 1998) . Currie and colleagues reported that the expression levels of Hsp70 and Hsp27 were significantly increased in the MCAO mouse model (Currie et al., 2000; Dhodda et al., 2004) . Here, we found that Hspa1b and Hspa1a ranked as the top 2 genes based on the differential expression of mRNAs, suggesting neuroprotective roles of heat shock proteins during ischemic injury. Moreover, researchers have observed that IPC induces the release of Ca 2+ in the cytosol and
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14 activates CaMK and CREB (Mabuchi et al., 2001) . Activating transcription factor 3 (Atf3), a nuclear calcium-regulated gene, is a direct target of CREB during signaling cascades and is involved in the protection against dendritic beading which leads to neuronal network dysfunction and cell death (Ahlgren et al., 2014) . Additionally, overexpression of Atf3 in vivo can reduce brain damage following the ischemic insult in mice by buildup of a "neuroprotective shield" after by the formation of a calcium/calmodulin complex which initiates a response at the genomic level (Zhang et al., 2011b ). The expression of this neuroprotective gene was also found to increase during as a response to IPC-induced protection. Heme oxygenase 1 (Hmox1) acts as a phase 2 electrophilic inducer downstream of the Keap1-Nrf2 pathway, this gene encodes for an enzyme which catabolizes free heme groups, up-regulates IL-10 IL-1RA, thus preventing against oxidative stress through anti-inflammatory mechanisms (Piantadosi et al., 2011) . Specifically, resistance to oxidative stress and neuronal cell death in the cerebellar granule neurons of Hmox1 transgenic mice were protected from stressful pathological events (Chen et al., 2000) . Activity-regulated cytoskeleton-associated protein (Arc) (also known as Arg3.1) is one of neuronal activity regulated molecules; Arc mRNA can rapidly accumulate in dendritic spines in response to neuronal activity, this change in function is able to target and activate synapses (Lyford et al., 1995; Farris et al., 2014; Na et al., 2016) . Additionally, Arc plays a significant role in the regulation surface α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor trafficking, which provides necessary contributions to neuroprotection and homeostatic maintenance of neuronal plasticity (Peebles et al., 2010) . The expression of the previously described genes and their products are consistent with our RNA-seq results. The consistency between our results and previously described studies in the literature demonstrate the accuracy and reliability of employing IPC models for this paper.
In this study, we also confirmed that three IPC-induced genes (Stc2, Arid5a and Nptx2) have neuroprotective functions against the in vitro ischemia OGD induced cytotoxicity. Stc2 is a glycoprotein hormone that has been identified as a biomarker of tumor onset, and this gene is highly expressed in several cancer types and facilitates tumor invasion and metastasis (Kita et al., 2011) . Furthermore, Stc2 is a HIF-1 target protein that is involved in the regulation of cell proliferation under hypoxia (Law and Wong, 2010) . Stc2 is also termed as a necessary survival component in relation to
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15 unfolded protein response (UPR) (Ito et al., 2004) and as a negative modulator of Ca 2+ cytoplasmic entry maintenance and Ca 2+ homeostasis (Zeiger et al., 2011) . Stc2
showed neuroprotective effects in response to hippocampal degeneration by means of mitigating the levels of nitric oxide, TNF-α, and IL-1β (Byun et al., 2010) ; these results are in agreement with our findings.
Additionally, data is consistent with previous results, indicating that Arid5a expression was induced in the process of neuronal cell death or degeneration (Tanaka et al., 1998) . Arid5a is a member of the Arid protein family, which have diverse functions that are directly involved in the development of both tissue-specific gene expression and regulation of cell growth. Arid5a is a protein that can regulate both IL-6 and IFN-γ in response to LPS by stabilizing the local expression of IL-6 and T-bet mRNA, respectively (Masuda et al., 2013; Zaman et al., 2016) . In our present study, we found that IPC can induce Arid5a upregulation after MCAO, and recombinant lentivirus-mediated overexpression of Arid5a in primary neurons protected against OGD-mediated neurotoxicity. Those results have the potential to define a novel molecular function for Arid5a as a novel modulator of neuronal cell death. Nptx2
(also known as Narp) is a secreted immediate early gene regulated by synaptic activity in brain, and it plays a crucial role in the formation of excitatory synapses, especially GluA4-containing AMPA receptors (O'Brien et al., 1999; Gu et al., 2013) .
A recent study showed that postmortem human AD cortex and CSF displayed profound reductions in Nptx2 and GluA4, which demonstrated robust correlations with cognitive performance and hippocampal volume (Xiao et al., 2017) . Our present study illustrates that IPC elicited Nptx2 upregulation and its potential to protect neurons from damage. Additionally, we identified both Arid5a and Nptx2 as DMR A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 
